Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 1:362:109982.
doi: 10.1016/j.cbi.2022.109982. Epub 2022 May 20.

TRPC6 is altered in COVID-19 pneumonia

Affiliations

TRPC6 is altered in COVID-19 pneumonia

Gina Leidinger et al. Chem Biol Interact. .

Abstract

In this Letter to the Editor supportive data were presented to a recent paper published in this journal reporting the involvement of TRP channels in COVID-19 pneumonia and its role for new therapies. Since gene expression of TRP channels was found in human lung tissues the protein was not being reported so far. TRP channels are supposed to be involved in the pulmonary inflammation and its symptoms such as fever, cough and others. Here, TRPC6 was investigated in tissues of normal human lungs and of SARS-Cov-2 infected lungs in a preliminary study. Tissue was obtained post mortem from anatomical body donations during dissections and during pathological dissections (13 normal, 4 COVID-19 pneumoniae) and processed for immunohistochemistry. In normal lungs TRPC6 was found in the ciliated epithelium, in the wall of larger lung vessels and in the alveolar septa. In COVID-19 pneumonia the distribution of TRPC6 was different. Inflammatory lesions, cellular infiltrates, hyaline membranes and fibrosis were labelled intensively as well as dilated capillaries. These observations are from four patients with COVID-19 pneumonia.The observations do not elucidate the molecular mechanisms but support the view that TRPC6 channels are involved in normal physiology of normal human lungs and in COVID-19 pneumonia. TRPC6 might aggravate SARS-2 induced inflammation and could be a target for inhibiting drugs.

Keywords: COVID pneumonia; Human lung; Immunohistochemistry; TRPC6 channels; Therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
A representative microphotograph from an immunohistochemical staining on a section of normal lung tissue using anti-TRPC6 is shown. The ciliated epithelium is labelled (brown color, arrows) as well as the thick layers of smooth muscles in the bronchiolar walls (arrowheads).
Fig. 2
Fig. 2
A representative microphotograph from an immunohistochemical staining on a section of lung tissue of a patient with COVID-19 pneumonia using anti-TRPC6 is presented. The dilated capillaries are labelled (brown color, arrowhead) as well as fibrotic lesions (arrow).
Fig. 3
Fig. 3
A representative microphotograph from an immunohistochemical staining on a section of lung tissue of a patient with COVID-19 pneumonia using anti-TRPC6 is presented. Amorpheous, hyaline structures were labelled (brown color, arrows).

References

    1. Jaffal S.M., Abbas M.A. TRP channels in COVID-19 disease: potential targets for prevention and treatment. Chem. Biol. Interact. 2021;345 - PMC - PubMed
    1. Finney-Hayward T.K., Popa M.O., Bahra P., Li S., Poll C.T., Gosling M., Nicholson A.G., Russell R.E., Kon O.M., Jarai G., Westwick J., Barnes P.J., Donnelly L.E. Expression of transient receptor potential C6 channels in human lung macrophages. Am. J. Respir. Cell Mol. Biol. 2010;43(3):296–304. - PubMed
    1. Riccio A., Medhurst A.D., Mattei C., Kelsell R.E., Calver A.R., Randall A.D., Benham C.D., Pangalos M.N. mRNA distribution analysis of human TRPC family in CNS and peripheral tissues. Brain Res Mol Brain Res. 2002;109(1–2):95–104. - PubMed
    1. Büch T., Schäfer E., Steinritz D., Dietrich A., Gudermann T. Chemosensory TRP channels in the respiratory tract: role in toxic lung injury and potential as "sweet spots" for targeted therapies. Rev. Physiol. Biochem. Pharmacol. 2013;165:31–65. - PubMed
    1. Dietrich A. Modulators of transient receptor potential (TRP) channels as therapeutic options in lung disease. Pharmaceuticals. 2019;12(1) - PMC - PubMed